Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3011)
All Articles published online
|
Jul 28, 2009 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lakatos PL, Czegledi Z, Szamosi T, Banai J, David G, Zsigmond F, Pandur T, Erdelyi Z, Gemela O, Papp J, Lakatos L. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease. World J Gastroenterol 2009; 15(28): 3504-3510 [PMID: 19630105 DOI: 10.3748/wjg.15.3504] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i28/3504.htm |
| Number | Citing Articles |
| 1 |
Xiang Gao, Rong-ping Yang, Min-hu Chen, Ying-lian Xiao, Yao He, Bai-li Chen, Pin-jin Hu. Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn's disease. Scandinavian Journal of Gastroenterology 2012; 47(10): 1181 doi: 10.3109/00365521.2012.668931
|
| 2 |
Rishikesh Kalaria, Devendra Desai, Philip Abraham, Anand Joshi, Tarun Gupta, Sudeep Shah. Temporal Change in Phenotypic Behaviour in Patients with Crohn’s Disease: Do Indian Patients Behave Differently from Western and Other Asian Patients?. Journal of Crohn's and Colitis 2016; 10(3): 255 doi: 10.1093/ecco-jcc/jjv202
|
| 3 |
Fen Liu, Jian Tang, Lingna Ye, Jinyu Tan, Yun Qiu, Fan Hu, Jinshen He, Baili Chen, Yao He, Zhirong Zeng, Ren Mao, Qian Cao, Xiang Gao, Minhu Chen. Prophylactic Antitubercular Therapy Is Associated With Accelerated Disease Progression in Patients With Crohn's Disease Receiving Anti-TNF Therapy: A Retrospective Multicenter Study. Clinical and Translational Gastroenterology 2022; 13(6): e00493 doi: 10.14309/ctg.0000000000000493
|
| 4 |
Christopher Alexakis, Sonia Saxena, Vivek Chhaya, Elizabeth Cecil, Azeem Majeed, Richard Pollok. Smoking Status at Diagnosis and Subsequent Smoking Cessation: Associations With Corticosteroid Use and Intestinal Resection in Crohn's Disease. American Journal of Gastroenterology 2018; 113(11): 1689 doi: 10.1038/s41395-018-0273-7
|
| 5 |
Peter L. Lakatos, Nora Sipeki, Gyorgy Kovacs, Eszter Palyu, Gary L. Norman, Zakera Shums, Petra A. Golovics, Barbara D. Lovasz, Peter Antal-Szalmas, Maria Papp. Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn’s Disease. Journal of Crohn's and Colitis 2015; 9(10): 891 doi: 10.1093/ecco-jcc/jjv127
|
| 6 |
Yamile Zabana, Esther Garcia-Planella, Manuel van Domselaar, Míriam Mañosa, Jordi Gordillo, Antonio López-Sanromán, Eduard Cabré, Eugeni Domènech. Predictors of favourable outcome in inflammatory Crohn's disease. A retrospective observational study. Gastroenterología y Hepatología 2013; 36(10): 616 doi: 10.1016/j.gastrohep.2013.07.004
|
| 7 |
Lorant Gonczi, Talat Bessissow, Peter Laszlo Lakatos. Disease monitoring strategies in inflammatory bowel diseases: What do we mean by “tight control”?. World Journal of Gastroenterology 2019; 25(41): 6172-6189 doi: 10.3748/wjg.v25.i41.6172
|
| 8 |
Sandra Wenger, Susanna Nikolaus, Stefanie Howaldt, Bernd Bokemeyer, Andreas Sturm, Jan C. Preiss, Alain M. Schoepfer, Andreas Stallmach, Carsten Schmidt. Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease. Journal of Crohn's and Colitis 2012; 6(1): 21 doi: 10.1016/j.crohns.2011.06.006
|
| 9 |
Umar Darr, Nabeel Khan. Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature. Current Treatment Options in Gastroenterology 2017; 15(1): 116 doi: 10.1007/s11938-017-0130-6
|
| 10 |
Chuan Hua YANG, Juan DING, Yan GAO, Xiang CHEN, Zhao Bin YANG, Shu Dong XIAO. Risk factors that predict the requirement of aggressive therapy among Chinese patients with Crohn's disease. Journal of Digestive Diseases 2011; 12(2): 99 doi: 10.1111/j.1751-2980.2011.00484.x
|
| 11 |
Jia-Yin Yao, Yi Jiang, Jia Ke, Yi Lu, Jun Hu, Min Zhi. Development of a prognostic model for one-year surgery risk in Crohn’s disease patients: A retrospective study. World Journal of Gastroenterology 2020; 26(5): 524-534 doi: 10.3748/wjg.v26.i5.524
|
| 12 |
Samuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, Ana Rita Gonçalves, Paula Moura Santos, Ana Valente, Luís Araújo Correia, Helena Cortez‐Pinto, Fernando Magro. The degree of bowel remission predicts phenotype progression in Crohn's disease. United European Gastroenterology Journal 2024; 12(7): 891 doi: 10.1002/ueg2.12581
|
| 13 |
Fernando Magro, Eduardo Rodrigues-Pinto, Rosa Coelho, Patrícia Andrade, João Santos-Antunes, Susana Lopes, Claudia Camila-Dias, Guilherme Macedo. Is it Possible to Change Phenotype Progression in Crohn's Disease in the Era of Immunomodulators? Predictive Factors of Phenotype Progression. American Journal of Gastroenterology 2014; 109(7): 1026 doi: 10.1038/ajg.2014.97
|
| 14 |
Alyssa M. Parian, Gerard E. Mullin, Jost Langhorst, Amy C. Brown. Integrative Medicine. 2018; : 501 doi: 10.1016/B978-0-323-35868-2.00050-5
|
| 15 |
Eun Mi Song, Ho-Su Lee, Ye-Jee Kim, Eun Hye Oh, Nam Seok Ham, Jeongseok Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu, Suk-Kyun Yang. Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn’s Disease: A Nationwide Population-Based Study. Digestive Diseases and Sciences 2020; 65(4): 1189 doi: 10.1007/s10620-019-05819-9
|
| 16 |
Carlos Walter Sobrado, Natália Sousa Freitas Queiroz, Caio Almeida Perez. Biological Therapy for Inflammatory Bowel Disease. 2020; doi: 10.5772/intechopen.90204
|
| 17 |
Florian Rieder, Giovanni Latella, Fernando Magro, Elif S. Yuksel, Peter D. R. Higgins, Antonio Di Sabatino, Jessica R. de Bruyn, Jordi Rimola, Jorge Brito, Dominik Bettenworth, Gert van Assche, Willem Bemelman, Andre d’Hoore, Gianluca Pellino, Axel U. Dignass. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. Journal of Crohn's and Colitis 2016; 10(8): 873 doi: 10.1093/ecco-jcc/jjw055
|
| 18 |
Antonio Rispo, Nicola Imperatore, Anna Testa, Luigi Bucci, Gaetano Luglio, Giovanni Domenico De Palma, Matilde Rea, Olga Maria Nardone, Nicola Caporaso, Fabiana Castiglione. Combined Endoscopic/Sonographic-based Risk Matrix Model for Predicting One-year Risk of Surgery: A Prospective Observational Study of a Tertiary Centre Severe/Refractory Crohn’s Disease Cohort. Journal of Crohn's and Colitis 2018; 12(7): 784 doi: 10.1093/ecco-jcc/jjy032
|
| 19 |
Guillaume Savoye, Julia Salleron, Corinne Gower-Rousseau, Jean-Louis Dupas, Gwénola Vernier-Massouille, Mathurin Fumery, Véronique Merle, Eric Lerebours, Antoine Cortot, Dominique Turck, Jean-Louis Salomez, Marc Lemann, Jean-Frédéric Colombel, Alain Duhamel. Clinical predictors at diagnosis of disabling pediatric Crohnʼs disease. Inflammatory Bowel Diseases 2012; 18(11): 2072 doi: 10.1002/ibd.22898
|
| 20 |
Guillermo Bastida Paz, Olga Merino Ochoa, Mariam Aguas Peris, Manuel Barreiro-de Acosta, Yamile Zabana, Daniel Ginard Vicens, Daniel Ceballos Santos, Fernando Muñoz Núñez, David Monfort i Miquel, Ignacio Catalán-Serra, Valle García Sánchez, Carmen Loras Alastruey, Alfredo Lucendo Villarín, Jose Maria Huguet, Cristóbal de la Coba Ortiz, Xavier Aldeguer Manté, Antonio Palau Canós, Eugeni Domènech Morral, Pilar Nos. The Risk of Developing Disabling Crohn’s Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making. Digestive Diseases 2023; 41(6): 879 doi: 10.1159/000531789
|
| 21 |
Adam Rahman, Andrew Ross, J.A. Leighton, Drew Schembre, Lauren Gerson, Simon K. Lo, Irving Waxman, Charles Dye, Carol Semrad. Double-balloon enteroscopy in Crohn’s disease: findings and impact on management in a multicenter retrospective study. Gastrointestinal Endoscopy 2015; 82(1): 102 doi: 10.1016/j.gie.2014.12.039
|
| 22 |
Min Seob Kwak, Duk Hwan Kim, Soo Jung Park, Tae Il Kim, Sung Pil Hong, Won Ho Kim, Jae Hee Cheon. Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-85
|
| 23 |
Aranzazu Jauregui Amezaga, Gert Van Assche. Practical Approaches to “Top–Down” Therapies for Crohn’s Disease. Current Gastroenterology Reports 2016; 18(7) doi: 10.1007/s11894-016-0507-z
|
| 24 |
Zsuzsanna Kurti, Zsuzsanna Vegh, Lorant Gonczi, Peter L. Lakatos. Biomarkers in Inflammatory Bowel Diseases. 2019; : 9 doi: 10.1007/978-3-030-11446-6_2
|
| 25 |
Tao Li, Lei Gao, Lei Cao, Zhen Guo, Wenwei Qian, Yi Yin, Yi Li, Weiming Zhu. Changes in disease behaviour and location and factor analysis in patients with Crohn’s disease undergoing repeated-resections. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e555 doi: 10.1097/MEG.0000000000002145
|
| 26 |
Jong Lyul Lee. Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease. Annals of Coloproctology 2019; 35(5): 225 doi: 10.3393/ac.2019.10.11
|
| 27 |
William J. Sandborn, Stephen Hanauer, Gert Van Assche, Julián Panés, Stephanie Wilson, Joel Petersson, Remo Panaccione. Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases. Journal of Crohn's and Colitis 2014; 8(9): 927 doi: 10.1016/j.crohns.2014.02.021
|
| 28 |
George Khoudari, Emad Mansoor, Benjamin Click, Motasem Alkhayyat, Mohannad Abou Saleh, Preetika Sinh, Jeffry Katz, Gregory S. Cooper, Miguel Regueiro. Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients After Initiation of Biologics: A Cohort Study. Clinical Gastroenterology and Hepatology 2022; 20(5): e974 doi: 10.1016/j.cgh.2020.10.008
|
| 29 |
Marian C Aldhous, J Satsangi. The impact of smoking in Crohn's disease: no smoke without fire. Frontline Gastroenterology 2010; 1(3): 156 doi: 10.1136/fg.2010.001487
|
| 30 |
Riccardo Mager, Giulia Roda, Mohammad Khaled Shalaby, Stefania Vetrano. Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors. Current Drug Targets 2021; 22(2): 241 doi: 10.2174/1389450121666201020160803
|
| 31 |
Charles N Bernstein, Remo Panaccione, Zoann Nugent, Deborah A Marshall, Gilaad G Kaplan, Stephen Vanner, Levinus A Dieleman, Lesley A Graff, Anthony Otley, Jennifer Jones, Michelle Buresi, Sanjay Murthy, Mark Borgaonkar, Brian Bressler, Alain Bitton, Kenneth Croitoru, Sacha Sidani, Aida Fernandes, Paul Moayyedi. Crohn’s Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study. Inflammatory Bowel Diseases 2024; doi: 10.1093/ibd/izae055
|
| 32 |
Inger C. Solberg, Milada Cvancarova, Morten H. Vatn, Bjørn Moum. Risk Matrix for Prediction of Advanced Disease in a Population-based Study of Patients with Crohnʼs Disease (the IBSEN Study). Inflammatory Bowel Diseases 2014; 20(1): 60 doi: 10.1097/01.MIB.0000436956.78220.67
|
| 33 |
Yu-Jun Chen, Jin-Shen He, Shan-Shan Xiong, Man-Ying Li, Shu-Ling Chen, Bai-Li Chen, Yun Qiu, Qing-Qing Xia, Yao He, Zhi-Rong Zeng, Min-Hu Chen, Xiao-Yan Xie, Ren Mao. Bowel Stiffness Assessed by Shear-Wave Ultrasound Elastography Predicts Disease Behavior Progression in Patients With Crohn's Disease. Clinical and Translational Gastroenterology 2024; 15(4): e00684 doi: 10.14309/ctg.0000000000000684
|
| 34 |
Wojciech Blonski, Anna M. Buchner, Gary R. Lichtenstein. Clinical Predictors of Aggressive/Disabling Disease: Ulcerative Colitis and Crohn Disease. Gastroenterology Clinics of North America 2012; 41(2): 443 doi: 10.1016/j.gtc.2012.01.008
|
| 35 |
Vivek Chhaya, Sonia Saxena, Elizabeth Cecil, Venkataraman Subramanian, Vasa Curcin, Azeem Majeed, Richard C. G. Pollok. Impact of Timing and Duration of Thiopurine Treatment on First Perianal Surgery in Crohnʼs Disease. Inflammatory Bowel Diseases 2015; 21(2): 385 doi: 10.1097/MIB.0000000000000290
|
| 36 |
Florian Rieder, Claudio Fiocchi, Gerhard Rogler. Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases. Gastroenterology 2017; 152(2): 340 doi: 10.1053/j.gastro.2016.09.047
|
| 37 |
Dana Rachel Berg, Jean-Frederic Colombel, Ryan Ungaro. The Role of Early Biologic Therapy in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019; 25(12): 1896 doi: 10.1093/ibd/izz059
|
| 38 |
T. Nunes, M. J. Etchevers, E. Domènech, V. García-Sánchez, Y. Ber, M. Peñalva, O. Merino, P. Nos, E. Garcia-Planella, A. G. Casbas, M. Esteve, C. Taxonera Samsó, M. Montoro Huguet, J. P. Gisbert, M. D. Martín Arranz, M. F. García-Sepulcre, M. Barreiro- de Acosta, B. Beltrán, N. Alcaide Suárez, C. Saro Gismera, J. L. Cabriada, A. Cañas-Ventura, F. Gomollón, J. Panés. Smoking does influence disease behaviour and impacts the need for therapy in Crohn′s disease in the biologic era. Alimentary Pharmacology & Therapeutics 2013; 38(7): 752 doi: 10.1111/apt.12440
|
| 39 |
|
| 40 |
Elia Rosa Martínez Sánchez, Ana Solá Fernández, Domingo Pérez Palacios, Andrea Núñez Ortiz, María Dolores de la Cruz Ramírez, Eduardo Leo Carnerero, Claudio Trigo Salado, José Manuel Herrera Justiniano. Perianal Crohn�s disease: clinical implications, prognosis and use of resources. Revista Española de Enfermedades Digestivas 2021; doi: 10.17235/reed.2021.7918/2021
|
| 41 |
Cátia Arieira, Tiago Cúrdia Gonçaves, Francisca Dias de Castro, Maria João Moreira, José Cotter. Clinical course in Crohn’s disease: factors associated with behaviour change and surgery. Scandinavian Journal of Gastroenterology 2018; 53(10-11): 1222 doi: 10.1080/00365521.2018.1503709
|
| 42 |
Petra A Golovics, Laszlo Lakatos, Michael D Mandel, Barbara D Lovasz, Zsuzsanna Vegh, Zsuzsanna Kurti, Istvan Szita, Lajos S Kiss, Tunde Pandur, Peter L Lakatos. Prevalence and predictors of hospitalization in Crohn’s disease in a prospective population-based inception cohort from 2000-2012. World Journal of Gastroenterology 2015; 21(23): 7272-7280 doi: 10.3748/wjg.v21.i23.7272
|
| 43 |
Florian Rieder, Ellen M Zimmermann, Feza H Remzi, William J Sandborn. Crohn's disease complicated by strictures: a systematic review. Gut 2013; 62(7): 1072 doi: 10.1136/gutjnl-2012-304353
|
| 44 |
Rong Fan, Jie Zhong, Zheng-Ting Wang, Shu-Yi Li, Jie Zhou, Yong-Hua Tang. Evaluation of “top-down” treatment of early Crohn’s disease by double balloon enteroscopy. World Journal of Gastroenterology 2014; 20(39): 14479-14487 doi: 10.3748/wjg.v20.i39.14479
|
| 45 |
Jessika Barendregt, Myrthe de Jong, Jeoffrey J. Haans, Bart van Hoek, James Hardwick, Roeland Veenendaal, Andrea van der Meulen, Nidhi Srivastava, Rogier Stuyt, Jeroen Maljaars. Liver test abnormalities predict complicated disease behaviour in patients with newly diagnosed Crohn’s disease. International Journal of Colorectal Disease 2017; 32(4): 459 doi: 10.1007/s00384-016-2706-3
|
| 46 |
Sarah O’Donnell, Krzysztof Borowski, Osvaldo Espin-Garcia, Raquel Milgrom, Boyko Kabakchiev, Joanne Stempak, Deepah Panikkath, Bertus Eksteen, Wei Xu, A Hillary Steinhart, Gilaad G Kaplan, Dermot P B McGovern, Mark S Silverberg. The Unsolved Link of Genetic Markers and Crohn’s Disease Progression: A North American Cohort Experience. Inflammatory Bowel Diseases 2019; 25(9): 1541 doi: 10.1093/ibd/izz016
|
| 47 |
Pal Miheller, Lajos S Kiss, Mark Juhasz, Michael Mandel, Peter L Lakatos. Recommendations for identifying Crohn’s disease patients with poor prognosis. Expert Review of Clinical Immunology 2013; 9(1): 65 doi: 10.1586/eci.12.86
|
| 48 |
Hiroshi Nakase, Bora Keum, Byoung Duk Ye, Soo Jung Park, Hoon Sup Koo, Chang Soo Eun. Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2ndAsian Organization of Crohn's and Colitis (AOCC) meeting in Seoul. Intestinal Research 2016; 14(3): 231 doi: 10.5217/ir.2016.14.3.231
|
| 49 |
Eun Mi Song, Ho‐Su Lee, Ye‐Jee Kim, Eun Hye Oh, Nam Seok Ham, Jeongseok Kim, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang. Clinical outcomes and long‐term prognosis of perianal Crohn's disease in an Asian population. Journal of Gastroenterology and Hepatology 2021; 36(6): 1571 doi: 10.1111/jgh.15308
|
| 50 |
Francesca Di Candido. Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after
Surgery. Reviews on Recent Clinical Trials 2022; 17(4): 227 doi: 10.2174/1574887117666220811143426
|
| 51 |
Jose-Manuel Benitez, Edouard Louis. Can We Predict the High-Risk Patient?. Digestive Diseases 2014; 32(4): 328 doi: 10.1159/000358132
|
| 52 |
K Sahnan, A Askari, S O Adegbola, P J Tozer, R K S Phillips, A Hart, O D Faiz. Natural history of anorectal sepsis. British Journal of Surgery 2017; 104(13): 1857 doi: 10.1002/bjs.10614
|
| 53 |
Yamile Zabana, Esther Garcia-Planella, Manuel Van Domselaar, Míriam Mañosa, Jordi Gordillo, Antonio López San Román, Eduard Cabré, Eugeni Domènech. Does active smoking really influence the course of Crohn's disease? A retrospective observational study. Journal of Crohn's and Colitis 2013; 7(4): 280 doi: 10.1016/j.crohns.2012.03.020
|
| 54 |
Daniela Simian, Daniela Fluxá, Lilian Flores, Jaime Lubascher, Patricio Ibáñez, Carolina Figueroa, Udo Kronberg, Raúl Acuña, Mauricio Moreno, Rodrigo Quera. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. World Journal of Gastroenterology 2016; 22(22): 5267-5275 doi: 10.3748/wjg.v22.i22.5267
|
| 55 |
Turid Hammer, Kári R. Nielsen, Pia Munkholm, Johan Burisch, Elsebeth Lynge. The Faroese IBD Study: Incidence of Inflammatory Bowel Diseases Across 54 Years of Population-based Data. Journal of Crohn's and Colitis 2016; 10(8): 934 doi: 10.1093/ecco-jcc/jjw050
|
| 56 |
Joseph William Clinton, Raymond Keith Cross. Personalized Treatment for Crohn’s Disease: Current Approaches and Future Directions. Clinical and Experimental Gastroenterology 2023; : 249 doi: 10.2147/CEG.S360248
|
| 57 |
Claudia Ott, Angela Takses, Florian Obermeier, Elisabeth Schnoy, Bernd Salzberger, Martina Müller. How fast up the ladder? Factors associated with immunosuppressive or anti-TNF therapies in IBD patients at early stages: results from a population-based cohort. International Journal of Colorectal Disease 2014; 29(11): 1329 doi: 10.1007/s00384-014-2002-z
|
| 58 |
Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin-Biroulet, Silvio Danese. Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nature Reviews Gastroenterology & Hepatology 2022; 19(3): 169 doi: 10.1038/s41575-021-00543-0
|
| 59 |
Florian Rieder, Ian C. Lawrance, Andre Leite, Miquel Sans. Predictors of fibrostenotic Crohnʼs disease. Inflammatory Bowel Diseases 2011; 17(9): 2000 doi: 10.1002/ibd.21627
|
| 60 |
Gianluca Pellino, Guido Sciaudone, Francesco Selvaggi, Gabriele Riegler. Delayed diagnosis is influenced by the clinical pattern of Crohn’s disease and affects treatment outcomes and quality of life in the long term. European Journal of Gastroenterology & Hepatology 2015; 27(2): 175 doi: 10.1097/MEG.0000000000000244
|
| 61 |
Lajos Sándor Kiss, Péter László Lakatos. Prediction of the disease course in inflammatory bowel diseases. Orvosi Hetilap 2010; 151(8): 293 doi: 10.1556/oh.2010.28813
|
| 62 |
Bushra Farah Nasir, Lyn Griffiths, Aslam Nasir, Rebecca Roberts, Murray Barclay, Richard Gearry, Rodney A. Lea. Perianal Disease Combined With NOD2 Genotype Predicts Need for IBD-related Surgery in Crohn’s Disease Patients From a Population-based Cohort. Journal of Clinical Gastroenterology 2013; 47(3): 242 doi: 10.1097/MCG.0b013e318258314d
|
| 63 |
Patrycja Dudek, Renata Talar-Wojnarowska. Current Approach to Risk Factors and Biomarkers of Intestinal Fibrosis in Inflammatory Bowel Disease. Medicina 2024; 60(2): 305 doi: 10.3390/medicina60020305
|
| 64 |
Petra Anna Golovics, Péter László Lakatos, Gyula Dávid, Tünde Pandur, Zsuzsanna Erdélyi, Ágnes Horváth, Gábor Mester, Mihály Balogh, István Szipocs, Csaba Molnár, Erzsébet Komáromi, Barbara Dorottya Lovász, Miklós Szathmári, Lajos S. Kiss, László Lakatos. The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron’s disease, in Veszprém county, Hungary, a population-based cohort study. Orvosi Hetilap 2012; 153(14): 541 doi: 10.1556/OH.2012.29331
|
| 65 |
A. N. Kulaylat, C. S. Hollenbeak, W. Sangster, D. B. Stewart Sr. Impact of smoking on the surgical outcome of Crohn's disease: a propensity‐score matched National Surgical Quality Improvement Program analysis. Colorectal Disease 2015; 17(10): 891 doi: 10.1111/codi.12958
|
| 66 |
Steve Halligan, Darren Boone, Lucinda Archer, Tariq Ahmad, Stuart Bloom, Manuel Rodriguez-Justo, Stuart A Taylor, Sue Mallett. Prognostic biomarkers to identify patients likely to develop severe Crohn’s disease: a systematic review. Health Technology Assessment 2021; 25(45): 1 doi: 10.3310/hta25450
|
| 67 |
David G Walker, Horace R T Williams, Stephen P Kane, Joel E Mawdsley, Jayantha Arnold, Ian McNeil, Huw J W Thomas, Julian P Teare, Ailsa L Hart, Maxton C L Pitcher, Julian R F Walters, Sara E Marshall, Timothy R Orchard. Differences in Inflammatory Bowel Disease Phenotype between South Asians and Northern Europeans Living in North West London, UK. American Journal of Gastroenterology 2011; 106(7): 1281 doi: 10.1038/ajg.2011.85
|
| 68 |
Peter L. Lakatos, Zsuzsanna Vegh, Barbara D. Lovasz, Gyula David, Tunde Pandur, Zsuzsanna Erdelyi, Istvan Szita, Gabor Mester, Mihaly Balogh, Istvan Szipocs, Csaba Molnar, Erzsebet Komaromi, Petra A. Golovics, Michael Mandel, Agnes Horvath, Miklos Szathmari, Lajos S. Kiss, Laszlo Lakatos. Is Current Smoking Still an Important Environmental Factor in Inflammatory Bowel Diseases? Results from a Population-based Incident Cohort. Inflammatory Bowel Diseases 2013; 19(5): 1010 doi: 10.1097/MIB.0b013e3182802b3e
|
| 69 |
Vivek Chhaya, Sonia Saxena, Elizabeth Cecil, Venkataraman Subramanian, Vasa Curcin, Azeem Majeed, Richard C. Pollok. Emerging trends and risk factors for perianal surgery in Crohn’s disease: a 20-year national population-based cohort study. European Journal of Gastroenterology & Hepatology 2016; 28(8): 890 doi: 10.1097/MEG.0000000000000651
|
| 70 |
Jun Hwan Yoo, Stefan Holubar, Florian Rieder. Fibrostenotic strictures in Crohn’s disease. Intestinal Research 2020; 18(4): 379 doi: 10.5217/ir.2019.09148
|
| 71 |
Devendra Desai. Disease Behaviour in Patients with Crohn’s Disease: A Review. Gastroenterology & Hepatology: Open Access 2015; 3(2) doi: 10.15406/ghoa.2015.03.00076
|
| 72 |
Tim W Eglinton, Richard B Gearry. Clinical factors predicting disease course in Crohn’s disease. Expert Review of Clinical Immunology 2010; 6(1): 41 doi: 10.1586/eci.09.76
|
| 73 |
Eugeni Domènech, Sílvia Carrión, Esther Garcia-Planella, Míriam Mañosa, Jordi Gordillo, Mar Concepción, Carlos Guarner, Eduard Cabré. Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease. Inflammatory Bowel Diseases 2011; 17(4): 971 doi: 10.1002/ibd.21456
|
| 74 |
Carolina Palmela, Joana Torres, Marilia Cravo. New Trends in Inflammatory Bowel Disease. GE Portuguese Journal of Gastroenterology 2015; 22(3): 103 doi: 10.1016/j.jpge.2015.03.009
|
| 75 |
Peter Laszlo Lakatos, Petra Anna Golovics, Gyula David, Tunde Pandur, Zsuzsanna Erdelyi, Agnes Horvath, Gabor Mester, Mihaly Balogh, Istvan Szipocs, Csaba Molnar, Erzsebet Komaromi, Gabor Veres, Barbara Dorottya Lovasz, Miklos Szathmari, Lajos S Kiss, Laszlo Lakatos. Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009. American Journal of Gastroenterology 2012; 107(4): 579 doi: 10.1038/ajg.2011.448
|
| 76 |
Ian Craig Lawrance. Modifying T-cell trafficking to the intestinal as a potential management for inflammatory bowel disease. Expert Opinion on Investigational Drugs 2012; 21(7): 975 doi: 10.1517/13543784.2012.690030
|
| 77 |
Ian C Lawrance. Early investigational TNF receptor antagonists for the treatment of ulcerative colitis. Expert Opinion on Investigational Drugs 2015; 24(6): 761 doi: 10.1517/13543784.2015.1020371
|
| 78 |
P. J. Tozer, D. Burling, A. Gupta, R. K. S. Phillips, A. L. Hart. Review article: medical, surgical and radiological management of perianal Crohn’s fistulas. Alimentary Pharmacology & Therapeutics 2011; 33(1): 5 doi: 10.1111/j.1365-2036.2010.04486.x
|
| 79 |
Bushra F Nasir, Lyn R Griffiths, Aslam Nasir, Rebecca Roberts, Murray Barclay, Richard B Gearry, Rodney A Lea. An Envirogenomic Signature Is Associated with Risk of IBD-Related Surgery in a Population-Based Crohn’s Disease Cohort. Journal of Gastrointestinal Surgery 2013; 17(9): 1643 doi: 10.1007/s11605-013-2250-1
|
| 80 |
Choong Wui Cho, Myung-Won You, Chi Hyuk Oh, Chang Kyun Lee, Sung Kyoung Moon. Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors. Gut and Liver 2022; 16(2): 157 doi: 10.5009/gnl210118
|
| 81 |
Rute Maria Cerqueira, Paula M. Lago. Clinical factors predictive of Crohn’s disease complications and surgery. European Journal of Gastroenterology & Hepatology 2013; 25(2): 129 doi: 10.1097/MEG.0b013e32835a7eed
|
| 82 |
Laszlo Lakatos, Lajos S. Kiss, Gyula David, Tunde Pandur, Zsuzsanna Erdelyi, Gabor Mester, Mihaly Balogh, Istvan Szipocs, Csaba Molnar, Erzsebet Komaromi, Peter Laszlo Lakatos. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002–2006. Inflammatory Bowel Diseases 2011; 17(12): 2558 doi: 10.1002/ibd.21607
|
| 83 |
Alexandre Lopes de Carvalho, Natalie Fernanda Baqueiro Sena, Jamile Caramello Ortins Sampaio, Aline de Oliveira Trajano, Lina Maria Goes de Codes, Flávia de Castro Ribeiro Fidelis, Rogerio Souza Medrado de Alcantara, Marcelo da Silva Barreto. Profile of Crohn’s Disease Patients Who Underwent Anorectal Examination under Anesthesia. Journal of Coloproctology 2021; 41(03): 275 doi: 10.1055/s-0041-1730015
|
| 84 |
Amir Klein, Yoav Mazor, Amir Karban, Ofer Ben‐Itzhak, Yehuda Chowers, Edmond Sabo. Early histological findings may predict the clinical phenotype in Crohn’s colitis. United European Gastroenterology Journal 2017; 5(5): 694 doi: 10.1177/2050640616676435
|
| 85 |
Ulysses dos Santos Torres, Juliana Olsen Rodrigues, Melissa Silva Garcia Junqueira, Simone Uezato, João Gomes Netinho. The Montreal classification for Crohn's disease: clinical application to a Brazilian single-center cohort of 90 consecutive patients. Arquivos de Gastroenterologia 2010; 47(3): 279 doi: 10.1590/S0004-28032010000300013
|
| 86 |
Sophie Vieujean, Edouard Louis. Precision medicine and drug optimization in adult inflammatory bowel disease patients. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231173331
|
| 87 |
Eun Hye Oh, Kyunghwan Oh, Minkyu Han, Hyungil Seo, Kiju Chang, Sun-Ho Lee, Gwang-Un Kim, Eun Mi Song, Myeongsook Seo, Ho-Su Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye, John Green. Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn’s disease with poor prognostic factors. PLOS ONE 2017; 12(5): e0177479 doi: 10.1371/journal.pone.0177479
|
| 88 |
Jean-Frederic Colombel, Neeraj Narula, Laurent Peyrin-Biroulet. Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases. Gastroenterology 2017; 152(2): 351 doi: 10.1053/j.gastro.2016.09.046
|
| 89 |
Yoav Mazor, Itay Maza, Eduard Kaufman, Shomron Ben-Horin, Amir Karban, Yehuda Chowers, Rami Eliakim. Prediction of disease complication occurrence in Crohn's disease using phenotype and genotype parameters at diagnosis. Journal of Crohn's and Colitis 2011; 5(6): 592 doi: 10.1016/j.crohns.2011.06.002
|
| 90 |
H. Misteli, C. E. Koh, L. M. Wang, N. J. Mortensen, B. George, R. Guy. Myenteric plexitis at the proximal resection margin is a predictive marker for surgical recurrence of ileocaecal Crohn's disease. Colorectal Disease 2015; 17(4): 304 doi: 10.1111/codi.12896
|